MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.

SECCHIERO, Paola; MELLONI, Elisabetta; VOLTAN, Rebecca; ZAULI, Giorgio; Norcio A; Celeghini C

oai:iris.unife.it:11392/1608666

MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.

Authors: Paola SECCHIERO
Elisabetta MELLONI
Rebecca VOLTAN
Giorgio ZAULI
Norcio A
Celeghini C
Publication date: 1 January 2012
Publisher
Doi

Abstract

no abstact availabl

Similar works

Full text

Archivio istituzionale della ricerca - Università di Ferrara

oai:iris.unife.it:11392/160866...

Last time updated on 12/11/2016

This paper was published in Archivio istituzionale della ricerca - Università di Ferrara.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.